A0733012
6-Aminoindole , 97% , 5318-27-4
Synonym(s):
Indol-6-ylamine;NSC 82379
CAS NO.：5318-27-4
Empirical Formula: C8H8N2
Molecular Weight: 132.16
MDL number: MFCD02093959
EINECS: 627-713-5
| Pack Size | Price | Stock | Quantity |
| 250MG | RMB90.40 | In Stock |
|
| 1G | RMB340.80 | In Stock |
|
| 5G | RMB923.20 | In Stock |
|
| 25g | RMB2990.40 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 75-79 °C |
| Boiling point: | 161-166°C 2mm |
| Density | 1.268±0.06 g/cm3(Predicted) |
| Flash point: | 161-166°C/2mm |
| storage temp. | -20°C |
| solubility | soluble in Methanol |
| pka | 18.23±0.30(Predicted) |
| form | Crystalline Powder |
| color | White to brown |
| Sensitive | Air Sensitive |
| BRN | 112190 |
| CAS DataBase Reference | 5318-27-4(CAS DataBase Reference) |
Description and Uses
Reactant for preparation of:
- Inhibitors of mammalian target of rapamycin (mTOR ) protein
- Inhibitors of the AcrAB-TolC efflux pump
- Inhibitors of Gli1-mediated transcription in the Hedgehog pathway
- Potent DNA-topoisomerase II poisons and anti-MDR agents
- Protein kinase C θ (PKCθ) inhibitors
- Piperidine carboxamide as transient receptor potential cation channel subfamily V member 1 (TRPV1) antagonists
- Potent and selective blockers of the Nav1.8 sodium channel as potential analgesics for the treatment of neuropathic and inflammatory pain
- 5,6-fused heteroaromatic ureas as TRPV1 antagonists
- Allosteric enhancers of the A3 adenosine receptor
- Human liver glycogen phosphorylase (HLGP) inhibitors for the treatment of type 2 diabetes
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P261-P264-P270-P301+P312-P302+P352-P305+P351+P338 |
| Hazard Codes | Xn,Xi |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36 |
| WGK Germany | 3 |
| Hazard Note | Harmful |
| HazardClass | IRRITANT-HARMFUL, KEEP COLD |
| PackingGroup | III |
| HS Code | 29339900 |
